These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32219014)

  • 1. Influence of Menopausal Hormone Therapy on Body Composition and Metabolic Parameters.
    Costa GBC; Carneiro G; Umeda L; Pardini D; Zanella MT
    Biores Open Access; 2020; 9(1):80-85. PubMed ID: 32219014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women.
    Mandrup CM; Egelund J; Nyberg M; Lundberg Slingsby MH; Andersen CB; Løgstrup S; Bangsbo J; Suetta C; Stallknecht B; Hellsten Y
    Am J Obstet Gynecol; 2017 Apr; 216(4):384.e1-384.e11. PubMed ID: 28024987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study.
    Schubert CM; Rogers NL; Remsberg KE; Sun SS; Chumlea WC; Demerath EW; Czerwinski SA; Towne B; Siervogel RM
    Int J Obes (Lond); 2006 Feb; 30(2):251-60. PubMed ID: 16247511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study.
    Reubinoff BE; Wurtman J; Rojansky N; Adler D; Stein P; Schenker JG; Brzezinski A
    Fertil Steril; 1995 Nov; 64(5):963-8. PubMed ID: 7589642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Climacteric modifications in body weight and fat tissue distribution.
    Gambacciani M; Ciaponi M; Cappagli B; Benussi C; De Simone L; Genazzani AR
    Climacteric; 1999 Mar; 2(1):37-44. PubMed ID: 11910677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause.
    Haarbo J; Marslew U; Gotfredsen A; Christiansen C
    Metabolism; 1991 Dec; 40(12):1323-6. PubMed ID: 1961129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot CA
    Am J Obstet Gynecol; 1996 Dec; 175(6):1594-600. PubMed ID: 8987946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy.
    Di Carlo C; Tommaselli GA; Sammartino A; Bifulco G; Nasti A; Nappi C
    Menopause; 2004; 11(4):466-73. PubMed ID: 15243285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S; Moaya M; Faghihzadeh S
    Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
    Bassol S; Carranza-Lira S; Celis-Gonzalez C; Santoyo S; Murillo A; Martinez N; Santos J; Llaca V; de la Loza FR; Zarain J; da Fonseca AM; Camargos AF; Baracat EC; da Sá MF; Bayo J; Adaro L; Gurucharri C; Murga M; Siseles N; Sayegh F; Tempone A; Tempone LM; Tozzini RI; Boccanera R; Naranjo C; Sanchez F; Gomez G; Blanco S; Reyes-Marquez R; Albrecht G; Rios PC
    Maturitas; 2005 Mar; 50(3):189-95. PubMed ID: 15734600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
    Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions.
    Douchi T; Yamamoto S; Yoshimitsu N; Andoh T; Matsuo T; Nagata Y
    Maturitas; 2002 Aug; 42(4):301-6. PubMed ID: 12191853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adiponectin concentration and cardiovascular risk factors in climacteric women.
    Milewicz A; Zatonska K; Demissie M; Jêdrzejuk D; Dunajska K; Ilow R; Lwow F
    Gynecol Endocrinol; 2005 Feb; 20(2):68-73. PubMed ID: 15823824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause-related changes in body fat distribution.
    Toth MJ; Tchernof A; Sites CK; Poehlman ET
    Ann N Y Acad Sci; 2000 May; 904():502-6. PubMed ID: 10865795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study.
    Green JS; Stanforth PR; Rankinen T; Leon AS; Rao Dc Dc; Skinner JS; Bouchard C; Wilmore JH
    Metabolism; 2004 Sep; 53(9):1192-6. PubMed ID: 15334383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of VO2max and disease risk factors between perimenopausal and postmenopausal women.
    Lynch NA; Ryan AS; Berman DM; Sorkin JD; Nicklas BJ
    Menopause; 2002; 9(6):456-62. PubMed ID: 12439106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.